Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System Disease.
Saved in:
| Title: | Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System Disease. |
|---|---|
| Authors: | Rolan, Paul1,2 (AUTHOR) paul.rolan@actinogen.com.au, Seckl, Jonathan3 (AUTHOR), Taylor, Jack1 (AUTHOR), Harrison, John4,5,6 (AUTHOR), Maruff, Paul7 (AUTHOR), Woodward, Michael8 (AUTHOR), Mills, Richard9 (AUTHOR), Jaros, Mark10 (AUTHOR), Hilt, Dana1 (AUTHOR) |
| Source: | Clinical Pharmacology in Drug Development. Feb2025, Vol. 14 Issue 2, p105-115. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 183915823 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System Disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Rolan%2C+Paul%22">Rolan, Paul</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> paul.rolan@actinogen.com.au</i><br /><searchLink fieldCode="AR" term="%22Seckl%2C+Jonathan%22">Seckl, Jonathan</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Taylor%2C+Jack%22">Taylor, Jack</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Harrison%2C+John%22">Harrison, John</searchLink><relatesTo>4,5,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maruff%2C+Paul%22">Maruff, Paul</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Woodward%2C+Michael%22">Woodward, Michael</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mills%2C+Richard%22">Mills, Richard</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jaros%2C+Mark%22">Jaros, Mark</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hilt%2C+Dana%22">Hilt, Dana</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Clinical+Pharmacology+in+Drug+Development%22">Clinical Pharmacology in Drug Development</searchLink>. Feb2025, Vol. 14 Issue 2, p105-115. 11p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=183915823 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpdd.1496 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 105 Titles: – TitleFull: Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System Disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rolan, Paul – PersonEntity: Name: NameFull: Seckl, Jonathan – PersonEntity: Name: NameFull: Taylor, Jack – PersonEntity: Name: NameFull: Harrison, John – PersonEntity: Name: NameFull: Maruff, Paul – PersonEntity: Name: NameFull: Woodward, Michael – PersonEntity: Name: NameFull: Mills, Richard – PersonEntity: Name: NameFull: Jaros, Mark – PersonEntity: Name: NameFull: Hilt, Dana IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: Feb2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2160763X Numbering: – Type: volume Value: 14 – Type: issue Value: 2 Titles: – TitleFull: Clinical Pharmacology in Drug Development Type: main |
| ResultId | 1 |
